Results 101 to 110 of about 5,704,490 (283)

El cáncer ginecológico [PDF]

open access: yes, 2015
Gynecological cancer is a major health problem in Europe, as taken together, ovarian cancer, cancer of the uterus and cervical cancer, represent the third cause of cancer in women in Europe, after breast cancer and colorectal cancer, and also the third ...
González-Martín, Antonio
core   +2 more sources

Calidad de vida sexual en pacientes con diagnóstico de cáncer de mama y cáncer de cuello uterino [PDF]

open access: yes, 2016
Several researchers in Medicine, Sociology and Psychology have tried to solve the following question: What is the quality of sexual life in patients diagnosed with breast cancer and / or cervical cancer?
Barrios Arroyave, Freddy Andrés   +1 more
core   +4 more sources

Virus del papiloma humano, respuesta inmune y cáncer cervical: una relación compleja Human papillomavirus, immune response and cervical cancer: a complex relationship

open access: yesRevista Colombiana de Obstetricia y Ginecología, 2007
El cáncer de cuello uterino se considera como un grave problema de salud pública con una alta incidencia en los países en desarrollo. La infección, permanencia y replicación del virus de papiloma humano (HPV, por sus siglas en inglés) de alto riesgo a ...
Olga L Rincón   +3 more
doaj  

Visual Inspection Test with Acetic Acid for Cervical Cancer Screening: Willingness and Acceptability among Reproductive Age and Married Women

open access: yesAlthea Medical Journal, 2018
Background: Cervical cancer is a preventable disease, thus early screening test should be performed for early cervical cancer prevention. Previous studies showed that among all of the screening techniques, visual inspection with acetic acid is an ...
Rozaliamisah Binti Hassan   +2 more
doaj   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

open access: yesArthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

La vida sexual insegura como riesgo para cáncer cervicouterino en mujeres con displasia cervical [PDF]

open access: yes, 2019
Cervical cancer is a malignant disease that affects women mainly over 50 years old, ranks 2nd in cancer in women worldwide, in Mexico ranks 7th. The natural history of cervical cancer denotes premalignant lesions known as cervical dysplasias which in ...
Ruvalcaba Ledezma, Jesús Carlos   +1 more
core  

Comparación entre la citología cervical y la biopsia por colposcopia en el diagnóstico de cáncer cervical [PDF]

open access: yes, 2023
El cáncer cervicouterino representa uno de los principales causas de morbi-mortalidad femenina a nivel mundial por lo que se lo considera un problema de salud, se ha demostrado que el principal agente etiológico es el virus del papiloma humano o VPH, la ...
López Galarza, Juan Miguel
core   +1 more source

Vaccines against papillomavirus infections and disease Vacunas contra el virus del papiloma humano y cáncer cervical invasor

open access: yesSalud Pública de México, 2003
Squamous cell carcinoma of the uterine cervix is the second cause of cancer-related deaths in women, the higher incidence being observed in developing countries.
Luisa Lina Villa
doaj  

Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer

open access: yesCancer Medicine, 2018
Maternal embryo leucine zipper kinase (MELK) is highly expressed in a variety of malignant tumors and involved in cell cycle regulation, cell proliferation, apoptosis, tumor formation etc However, the biological effects of MELK in cervical cancer are ...
Juan Wang   +7 more
doaj   +1 more source

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.

open access: yesJournal of Clinical Oncology, 2019
PURPOSE KEYNOTE-158 ( ClinicalTrials.gov identifier: NCT02628067) is a phase II basket study investigating the antitumor activity and safety of pembrolizumab in multiple cancer types.
H. Chung   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy